Oaktree Acquisition Corp. III Life Sciences (OACC) stock
Close on Nov 12, 2026Market cap $263.04MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $263.04M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- $6.75M
Trading
- Previous close
- $10.70
- Open
- $10.70
- Day's range
- $10.70 – $10.70
- Average volume (20 days)
- 7,970
- 52-week range
- $10.50 – $10.93
- RSI (14 days)
- 46.0
- Volatility (1 year)
- 5.0%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | OACC | S&P 500 | Difference | OACC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -0.5% | -2.7% | +2.2 pts | ||
| 3 months | -0.6% | -1.7% | +1.2 pts | ||
| Year to date | +1.1% | +11.9% | −10.8 pts | ||
| 1 year | +0.9% | +12.0% | −11.0 pts |
Two years at a glance
Fiscal years 2024 to 2025 and trailing twelve months, USD
Operating income
Net income
Press releases
Releases Oaktree Acquisition Corp. III Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K
About Oaktree Acquisition Corp. III Life Sciences
Blank Checks
Oaktree Acquisition Corp. III Life Sciences is a blank check company established to execute a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The entity focuses its acquisition efforts primarily on companies within the healthcare and healthcare-related industries, with particular interest in biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors. Because the company has not yet consummated a transaction, it does not currently provide commercial products or services to external customers.
Company profile, executives and historyOaktree Acquisition Corp. III Life Sciences stock: common questions
What is Oaktree Acquisition Corp. III Life Sciences's stock price?
OACC closed at $10.70 on Nov 12, 2026, up 0.00% on the day. Over the past 52 weeks it traded between $10.50 and $10.93.
What is Oaktree Acquisition Corp. III Life Sciences's market cap?
Oaktree Acquisition Corp. III Life Sciences was worth $263.04M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
Does Oaktree Acquisition Corp. III Life Sciences pay a dividend?
No. Oaktree Acquisition Corp. III Life Sciences has not paid a cash dividend over the last twelve months.
How has OACC stock performed over the past year?
Including dividends, OACC returned +0.9% over the past year, against +12.0% for the S&P 500.
Who are Oaktree Acquisition Corp. III Life Sciences's competitors?
Companies most similar to Oaktree Acquisition Corp. III Life Sciences by business, industry and size include BLUW, LPAA, SORN, HLXC, EMIS.
See a number that looks wrong?